How to Help Your Patients Find Dicloxacillin in Stock: A Provider's Guide

When a patient calls your office to report that no pharmacy near them has Dicloxacillin in stock, the downstream workload falls on your staff: callbacks, fax prescriptions, prior authorization re-evaluations. This guide is designed to help practices build a simple, repeatable workflow to support patients facing Dicloxacillin availability challenges — without overwhelming clinical staff.

Understanding the Availability Problem

Dicloxacillin is a narrow-spectrum penicillinase-resistant antibiotic with a relatively small prescribing volume compared to amoxicillin, cephalexin, or azithromycin. Pharmacies stock based on demand, which means many locations keep only minimal quantities. The brand Dynapen has been off the market for years, leaving only generics with a limited manufacturer base.

There is no current FDA-declared national shortage of Dicloxacillin, but localized stock-outs are common. Patients may call 5-10 pharmacies without finding stock. This is not a one-off event — it's a structural supply characteristic prescribers can plan for.

Step 1: Send Prescriptions to Multiple Pharmacies When Appropriate

If you practice in an area where Dicloxacillin is regularly difficult to find, consider checking with your local pharmacies proactively about their stock. Building a short list of 2-3 pharmacies (including at least one independent) that reliably stock Dicloxacillin allows your staff to route new prescriptions accordingly.

Step 2: Know Your Clinically Equivalent Alternatives

Having an automatic alternative prescription ready saves time for your staff and gets your patients started on treatment faster. For MSSA skin and soft tissue infections, the most commonly used alternatives to Dicloxacillin include:

Cephalexin: 500 mg PO BID-QID; clinically equivalent for MSSA SSTIs; universally available; can be taken with food. First-line alternative per IDSA guidelines.

TMP-SMX: 1-2 DS tablets PO BID; covers MSSA and MRSA; preferred when MRSA cannot be excluded. Not appropriate for streptococcal-only infections.

Clindamycin: 300-450 mg PO TID; useful for penicillin/cephalosporin-allergic patients; covers MSSA and many MRSA strains.

Step 3: Use medfinder for Providers to Locate Stock

Rather than having office staff call pharmacies one by one, direct patients to medfinder for Providers. This service calls local pharmacies on the patient's behalf to check Dicloxacillin stock availability and texts the patient which pharmacies have it. This reduces the back-and-forth between patient, office, and pharmacy.

Step 4: Build a Transfer Workflow for Refractory Availability Cases

When a patient has already exhausted local options and needs Dicloxacillin specifically (e.g., culture-directed therapy or specific intolerance to alternatives), consider these escalation options:

Mail-order pharmacy: Insurer-affiliated mail-order pharmacies (Express Scripts, CVS Caremark, OptumRx) can often source niche generics with a 2-5 business day turnaround.

Hospital outpatient pharmacy: If your practice is affiliated with a hospital system, the outpatient pharmacy may have more reliable access through institutional wholesaler contracts.

Independent pharmacy special order: Independent pharmacies can typically source Dicloxacillin through secondary wholesalers within 24-48 hours when chain pharmacies cannot.

Communicating With Patients About Availability Delays

Patients may be frustrated when they can't fill a prescription immediately — especially for an acute bacterial infection. Proactive communication from your practice can reduce confusion:

Inform patients at the point of prescribing that Dicloxacillin may require calls to multiple pharmacies

Provide patients with a list of local independent pharmacies known to stock it

Establish a standing protocol: if Dicloxacillin is unavailable within 24 hours, the practice will send an alternative prescription automatically

Direct patients to medfinder for real-time pharmacy availability assistance

When Culture Data Is Available

When treating culture-confirmed MSSA infections, Dicloxacillin is clinically appropriate. However, if the organism demonstrates susceptibility to cephalexin (as MSSA routinely does), de-escalation to cephalexin is clinically justified and operationally simpler. Document the substitution rationale and ensure the patient understands the change.

For a more detailed supply chain briefing and prescribing decision framework, see our companion article: Dicloxacillin shortage: What providers and prescribers need to know in 2026.